Literature DB >> 31629154

A hypothetical proposal for association between migraine and Meniere's disease.

Brooke Sarna1, Mehdi Abouzari2, Harrison W Lin1, Hamid R Djalilian3.   

Abstract

Meniere's disease (MD) is a chronic condition affecting the inner ear whose precise etiology is currently unknown. We propose the hypothesis that MD is a migraine-related phenomenon which may have implications for future treatment options for both diseases. The association between MD and migraine is both an epidemiological and a mechanistic one, with up to 51% of individuals with MD experiencing migraine compared to 12% in the general population. The presence of endolymphatic hydrops in those with MD may be the factor that unites the two conditions, as hydropic inner ears have an impaired ability to maintain homeostasis. Migraine headaches are theorized to cause aura and symptoms via spreading cortical depression that ultimately results in substance P release, alterations in blood flow, and neurogenic inflammation. Chronically hydropic inner ears are less able to auto-regulate against the changes induced by active migraine attacks and may ultimately manifest as MD. This same vulnerability to derangements in homeostasis may also explain the common triggering factors of both MD attacks and migraine headaches, including stress, weather, and diet. Similarly, it may explain the efficacy of common treatments for both diseases: current migraine treatments such as anti-hypertensives and anti-convulsants have shown promise in managing MD. Though the etiology of both MD and migraine is likely multifactorial, further exploration of the association between the two conditions may illuminate how to best manage them in the future. MD is likely a manifestation of cochleovestibular migraine, which occurs as a result of migraine related changes in both the cochlea and vestibule.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Association; Cochleovestibular migraine; Endolymphatic hydrops; Meniere’s disease; Migraine headache

Mesh:

Substances:

Year:  2019        PMID: 31629154      PMCID: PMC6957735          DOI: 10.1016/j.mehy.2019.109430

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  82 in total

Review 1.  Meniere's disease: an evidence based approach to assessment and management.

Authors:  I Syed; C Aldren
Journal:  Int J Clin Pract       Date:  2012-02       Impact factor: 2.503

2.  Meniere's syndrome and endolymphatic hydrops. Double-blind temporal bone study.

Authors:  S D Rauch; S N Merchant; B A Thedinger
Journal:  Ann Otol Rhinol Laryngol       Date:  1989-11       Impact factor: 1.547

3.  Odorant substances that trigger headaches in migraine patients.

Authors:  R P Silva-Néto; M F P Peres; M M Valença
Journal:  Cephalalgia       Date:  2013-07-05       Impact factor: 6.292

4.  Migraine, as compared to other headaches, is worse during midnight-sun summer than during polar night. A questionnaire study in an Arctic population.

Authors:  R Salvesen; S I Bekkelund
Journal:  Headache       Date:  2000 Nov-Dec       Impact factor: 5.887

5.  Can migraine damage the inner ear?

Authors:  H Lee; I Lopez; A Ishiyama; R W Baloh
Journal:  Arch Neurol       Date:  2000-11

Review 6.  An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action.

Authors:  R P Shank; J F Gardocki; A J Streeter; B E Maryanoff
Journal:  Epilepsia       Date:  2000       Impact factor: 5.864

7.  A Historical Recount: Discovering Menière's Disease and Its Association With Migraine Headaches.

Authors:  Omid Moshtaghi; Ronald Sahyouni; Harrison W Lin; Yaser Ghavami; Hamid R Djalilian
Journal:  Otol Neurotol       Date:  2016-09       Impact factor: 2.311

8.  The effect of daily caffeine use on cerebral blood flow: How much caffeine can we tolerate?

Authors:  Merideth A Addicott; Lucie L Yang; Ann M Peiffer; Luke R Burnett; Jonathan H Burdette; Michael Y Chen; Satoru Hayasaka; Robert A Kraft; Joseph A Maldjian; Paul J Laurienti
Journal:  Hum Brain Mapp       Date:  2009-10       Impact factor: 5.038

9.  Migraine treated using a prophylactic combination of candesartan and hydrochlorothiazide (ECARD Combination Tablets LD).

Authors:  Hisanao Akiyama; Yasuhiro Hasegawa
Journal:  Pain Pract       Date:  2012-11-05       Impact factor: 3.183

10.  Migraine and Ménière's disease: is there a link?

Authors:  A Radtke; T Lempert; M A Gresty; G B Brookes; A M Bronstein; H Neuhauser
Journal:  Neurology       Date:  2002-12-10       Impact factor: 9.910

View more
  4 in total

Review 1.  Vestibular and auditory manifestations of migraine.

Authors:  Tania Benjamin; Danielle Gillard; Mehdi Abouzari; Hamid R Djalilian; Jeffrey D Sharon
Journal:  Curr Opin Neurol       Date:  2022-02-01       Impact factor: 5.710

Review 2.  Migrainous Vertigo, Tinnitus, and Ear Symptoms and Alternatives.

Authors:  Mehdi Abouzari; Karen Tawk; Darlene Lee; Hamid R Djalilian
Journal:  Otolaryngol Clin North Am       Date:  2022-09-21       Impact factor: 1.866

Review 3.  Perilymphatic Fistula: A Review of Classification, Etiology, Diagnosis, and Treatment.

Authors:  Brooke Sarna; Mehdi Abouzari; Catherine Merna; Shahrnaz Jamshidi; Tina Saber; Hamid R Djalilian
Journal:  Front Neurol       Date:  2020-09-15       Impact factor: 4.003

4.  Tinnitus and Subjective Hearing Loss are More Common in Migraine: A Cross-Sectional NHANES Analysis.

Authors:  Khodayar Goshtasbi; Mehdi Abouzari; Adwight Risbud; Navid Mostaghni; Ethan G Muhonen; Elaine Martin; Hamid R Djalilian
Journal:  Otol Neurotol       Date:  2021-10-01       Impact factor: 2.619

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.